Similarly, peptide hormones like gastrin-releasing peptide (GRP) and its more stable precursor pro-GRP, when combined with established markers such as NSE, improve sensitivity in detecting small cell lung cancer (SCLC) [60]. Here, GRP is linked to small cell lung carcinoma.